LAZIOcrea won the 2017 Pentaho Excellence Award in ROI, a category that recognizes the use of Pentaho to make a positive impact on business, society and the planet.
RISING HEALTHCARE COSTS PROMPTS ONE-OF-A-KIND DATA INTEGRATION PROJECT
LAZIOcrea supports Regione Lazio, the large region in central Italy that includes Rome and more than 6 million citizens. They have administrative and technical infrastructure services for government programs co-funded by the European Union.
Healthcare costs make up the majority of the regional government’s expenditures. In 2016, Regione Lazio kicked off a groundbreaking project—the first and only project of its kind in Europe—designed to monitor and reduce pharmaceutical drug costs. The region needed to determine which doctors wrote the most prescriptions, the cost associated with these prescriptions and how often the same prescriptions were written.
SINGLE VIEW OF DATA DRIVES NEW INSIGHTS AND INNOVATION
LAZIOcrea was tasked with creating a single view of data from patients, doctors and pharmacies. There are enormous volumes and varieties of data to be collected and digitized. Each month, 5.5 million prescriptions are written and 11 million prescription barcodes are recorded from 25,000 doctors, 10 health systems, eight hospitals and 1,500 pharmacies.
Working with implementation partner BNova, LAZIOcrea built a Medical Prescription Analysis System using Pentaho Enterprise Edition for the entire data pipeline—from ingestion to blending to visualization. Data can now be extracted easily and viewed and analyzed in new and innovative ways. Future uses for the single view of data include a data lake, machine learning algorithms, and doctor scorecards.
PUBLIC HEALTH AND BUDGETS BENEFIT FROM SINGLE DATA VIEW
The region now knows, with greater accuracy, the type and frequency of medicine prescribed. There are fewer unnecessary prescriptions—the kinds that often lead to drug abuse. And there is an adequate supply of medicine in emergencies, such as the devastating earthquake that struck the region in 2016.
Not only has pharmaceutical policy improved, costs have decreased dramatically. Prescription drug expenses have shrunk from €162 to €154.8 per citizen since 2014, for a total savings of €43 million. The region now has confidence funds will be in place to cover healthcare expenses for its citizens.
Learn more about the other 2017 Pentaho Excellence Award Winners.